IntroductionThe Systemic Aspergillosis and Systemic Candidiasis Market focuses on therapeutic and diagnostic solutions for managing severe fungal infections that affect immunocompromised individuals. Aspergillus and Candida species are among the most common opportunistic fungal pathogens responsible for systemic infections in patients with weakened immune systems, such as those undergoing organ transplants, chemotherapy, or long-term ICU stays. […]